Rubio JB

Language: Spanish
References: 18
Page: 3-5
PDF size: 29.80 Kb.

Text Extraction

No abstract

REFERENCES

1. Somarouthu B, Kalva SP. Diagnosing deep vein thrombosis. Postgrad Med 2010; 122(2): 66-73.

2. Adam SS, Key NS, Greenberg CS. D-dimer antigen: current concepts and future prospects. Blood 2009; 113(13): 2878-2887.

3. Wada H, Usui M, Sakuragawa N. Hemostatic abnormalities and liver diseases. Semin Thromb Hemost 2008; 34: 772-778.

4. Dong-Wha K, Sung-Hee Y, Sail C, Kyum YK, Sun UK, Jae YK, Jond SK. Inflammatory and hemostatic biomarkers associated with early recurrent ischemic lesions in acute ischemic stroke. Stroke 2009; 40: 1653-1658.

5. Kretz CA, Vaezzadeh N, Gross PL. Tissue factor and thrombosis models. Arterioscler Thromb Vasc Biol 2010; 30: 900-908.

6. Tanaka KA, Key NS, Jerrold HL. Blood coagulation: hemostasis and thrombin regulation. Anesth Analg 2009; 108: 1433-1446.

7. Bozic M, Stegnar M. D-dimer, other markers of haemostatic activation and soluble adhesion molecules in patients with different clinical probabilities of deep vein thrombosis. Thromb Res 2003; 108: 107-114.

8. Lijfering WM, Middeldorp S, Veeger NJGM, Hamulya´k K, Prins MH, Bûller HL, van der Meer J. Risk of recurrent venous thrombosis in homozygous carriers and double heterozygous carriers of factor V Leiden and prothrombin G20210A. Circulation 2010; 121: 1706-1712.

9. Eichinger SH, Jandeck LM, Kyrle PA. Risk Assessment of recurrence in patients with unprovoked deep vein thrombosis or pulmonary embolism the Vienna prediction model. Circulation 2010; 121: 1630-1636.

10. Cohen D, Berger SP, Steup-Beekman GM, Bloemenkamp KW, Bajema IM. Diagnosis and management of the antiphospholipid syndrome. BMJ 2010; 340(15): 2541.

11. von Hundelshausen P, Weber C. Platelets as immune cells: bridging inflammation and cardiovascular disease. Circ Res 2007; 100: 27-40.

12. Gawaz M, Langer H, May AE. Platelets in inflammation and atherogenesis. J Clin Invest 2005; 115: 3378-3384.

13. Xu J, Lupu F, Esmon CT. Inflammation, innate immunity and blood coagulation. Hâmostaseologie 2010; 30: 5-9.

14. van Leuven SI, Franssen R, Kastelein JJ, Levi M, Stroes ESG, Tak PP. Systemic inflammation as a risk factor for atherothrombosis. Rheumatology 2008; 47: 3-7.

15. Wolberg ASC, Robert A. Thrombin generation, fibrin clot formation and hemostasis. Transfusion and Apheresis Science 2008; 38: 15-23.

16. Woollard KJ, Geissmann F. Monocytes in atherosclerosis: subsets and functions. Nat Rev Cardiol 2010; 7(2): 77-96.

17. Nojima J, Suehisa E, Kuratsune H, Kanakura Y. The presence of anti-phosphatidylserine/prothrombin antibodies as risk factor for both arterial and venous thrombosis in patients with systemic lupus erythematous. Hematologica 2006; 91: 699-702.

18. Pierangeli S, Chen PP, González EB. Antiphospholipid antibodies and the antiphospholipid syndrome: an update on treatment and pathogenic mechanisms. Curr Opin Hematol 2006; 13: 366-375.